Navigation Links
Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
Date:5/2/2013

ortization of convertible debt discount

7.713.3Non-cash accretion and fair value adjustments of contingent consideration liability

5.88.2Clean energy investment pre-tax loss (b)

4.44.2Acquisition related costs (primarily included in selling, general and administrative expense)

19.4—Restructuring and other special items included in:Cost of sales

10.92.2Research and development expense

23.31.4Selling, general and administrative expense

24.024.4Other income, net

6.82.3Tax effect of the above items and other income tax related items

(57.2)(50.3)Adjusted net earnings attributable to Mylan Inc. and adjusted diluted EPS

$

245.9$

0.62$

224.5$

0.52Weighted average diluted common shares outstanding

399.0432.4(a)
Purchase accounting related amortization expense for the three months ended March 31, 2013 includes $5.1 million of in-process research and development asset impairment charges.

(b)
Adjustment represents exclusion of the pre-tax loss related to Mylan's investment in a clean energy partnership, the activities of which qualify for income tax credits under section 45 of the Internal Revenue Code. Amount is included in other income (expense), net. Certain insignificant prior period amounts of other revenue, cost of sales, operating expenses and the related EBITDA and Adjusted EBITDA have been reclassified to other income (expense), net to conform to the presentation for the current period. The reclassifications had no impact on the previously reported net earnings attributable to Mylan Inc. common shareholders.

Below is a reconciliation of GAAP net earnings attributable to Mylan Inc. to adjusted EBITDA for the three months ended March 31, 2013 and 2012 (in millions):

 Three Months EndedMarch 31,20132012GAAP net earnings attributable to Mylan Inc.

$

106.9$

129.1Add
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
4. Mylan Launches Generic Lipitor® in Five European Countries
5. Mylan Launches Generic Version of Plavix® Tablets
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Mylan Launches Generic Version of Viramune® Tablets
8. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
9. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
10. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
11. Mylan Launches Generic Version of Lipitor®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014  Researchers from the North American ... elevates calcium levels too high, 1 putting ... problems. Women close to menopause are commonly ... to prevent diseases such as osteoporosis, to which they ... women determine how much calcium they typically get through ...
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
(Date:7/23/2014)... , July 23 2014 Ampio Pharmaceuticals, ... its new headquarters, manufacturing and research facility: ... 80112 Direct: (720) 437-6500 ... efficient, pharmaceutical drug manufacturing facility will be fully operational ... the first batches of Ampion TM necessary to ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... 2011 Assured Pharmacy (Pink Sheets: APHY ), ... than 3,000 sufferers of chronic pain announced that total sales ... 2010 were $1,514,984 which equates to $70,464 per business day. ... total sales of $1,348,344 for December 2009 which equates to ...
... 2011 BioDelivery Sciences International, Inc. ... outcome of a pre-Investigational New Drug (pre-IND) meeting ... on the development program for BEMA Buprenorphine/Naloxone, BDSI,s ... discussed is based on pharmacokinetic and safety data ...
Cached Medicine Technology:Assured Pharmacy Reports Same Store Sales for the Month of December 2010 2Assured Pharmacy Reports Same Store Sales for the Month of December 2010 3BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 2BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 3
(Date:7/23/2014)... 2014 The European Vitamins Market report ... analysis and projection of revenue. The market in Europe ... 2012 to $1,202.08 million by 2018, at a CAGR ... the TOC of the European Vitamins Market report, to ... also provides a glimpse of the segmentation in the ...
(Date:7/23/2014)... RFcnn.com, a distinguished electrical equipment retailer, has ... . What’s more, the company has decided to provide big ... who place an order for the company’s brand new SMA ... , The high quality SMA JACK from RFcnn.com Provides ... superb quality electrical equipment to help make things much easier ...
(Date:7/23/2014)... 23, 2014 "I wanted a better way ... as my blood sugar, blood pressure and pulse rate," said ... to have to carry along a bunch of different devices, ... He developed the Master III to make it easier to ... one convenient unit. The accessory enables the user to have ...
(Date:7/23/2014)... hued dyes, George Mason University researchers discovered an ... other, possibly leading to new treatments for cancer, ... George Mason researchers unraveled the mystery of deciphering ... "One protein interlocks with another protein like adjacent ... a signal down the line to the next ...
(Date:7/23/2014)... According to a new market research report of ... IP, SOC IP), Design Architecture (Hard IP, Soft IP), ... - Forecast & Analysis to 2013 - 2020", the ... a CAGR of 12.6% from 2014 to 2020 and ... 76 market data tables with 60 figures spread through ...
Breaking Medicine News(10 mins):Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:New Collection of SMA JACK Released by China Electrical Accessory Manufacturer RFcnn 2Health News:Researchers unlock the protein puzzle 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6
... who receive higher disability ratings for work-related back injuries ... those who get lower ratings.// ,This ... relationship between Workers’ Compensation settlements for back pain and ... showing ‘blacks receive less treatment for their back pain ...
... Researchers at Mayo Clinic have successfully isolated nanoparticles from ... RNA and DNA that appear to be associated with ... December issue of the Journal of Investigative Medicine, are ... the mystery of whether nanoparticles are viable living forms ...
... have a genetic predisposition. //This study is lead by ... helix. ,Collaborated Research is being launched by Researchers ... Institute for Medical Research and Cold Spring Harbor Laboratory ... ,"For complex illnesses like bipolar disorder that vary dramatically ...
... but a medical aberration until recently—are now becoming a ... that has pediatricians at the Johns Hopkins Children’s Center, ... doctors have yet to quantify the precise increase and ... play some role—pediatricians agree that too much salt and ...
... welcomed the first formal agreement to deliver a fast, ... move as a win for patients and doctors alike. ... first organisation to sign up to deliver the new ... immediately after paying the doctor’s bill. ,The ...
... woman succumbed to bird flu.// With this, the total number of ... since March 2006. ,The woman aged 30 years had ... detected with H5N1 barely a few hours before she died. Though ... since mid- December, Doctors had not checked her out for ...
Cached Medicine News:Health News:Is Workers’ Comp. Settlements for Back Pain Fair 2Health News:Link Between Nanoparticles and Kidney Stones 2Health News:Link Between Nanoparticles and Kidney Stones 3Health News:Research on Bipolar Disorder Launched 2Health News:Kidney Stones Occurring More Often in Children 2